PCM
Perkins Capital Management’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,600
| Closed | -$70K | – | 111 |
|
|
2022
Q1 | $70K | Sell |
19,600
-460,300
| -96% | -$1.64M | 0.06% | 103 |
|
|
2021
Q4 | $1.88M | Sell |
479,900
-40,925
| -8% | -$160K | 1.27% | 28 |
|
|
2021
Q3 | $3.43M | Hold |
520,825
| – | – | 2.12% | 11 |
|
|
2021
Q2 | $3.21M | Sell |
520,825
-20,000
| -4% | -$123K | 1.82% | 15 |
|
|
2021
Q1 | $2.45M | Buy |
540,825
+172,425
| +47% | +$780K | 1.41% | 22 |
|
|
2020
Q4 | $2.21M | Buy |
368,400
+35,975
| +11% | +$216K | 1.45% | 25 |
|
|
2020
Q3 | $2.47M | Buy |
+332,425
| New | +$2.47M | 2.27% | 11 |
|
|
2020
Q1 | $646K | Buy |
254,267
+30,684
| +14% | +$78K | 0.78% | 45 |
|
|
2019
Q4 | $778K | Sell |
223,583
-8,700
| -4% | -$30.3K | 0.7% | 51 |
|
|
2019
Q3 | $1.08M | Sell |
232,283
-65,517
| -22% | -$303K | 0.93% | 41 |
|
|
2019
Q2 | $3.67M | Sell |
297,800
-33,350
| -10% | -$411K | 2.57% | 7 |
|
|
2019
Q1 | $4.4M | Buy |
331,150
+6,350
| +2% | +$84.4K | 2.9% | 6 |
|
|
2018
Q4 | $2.8M | Buy |
324,800
+106,300
| +49% | +$916K | 2.17% | 9 |
|
|
2018
Q3 | $1.64M | Buy |
218,500
+49,500
| +29% | +$371K | 0.98% | 31 |
|
|
2018
Q2 | $1.01M | Buy |
169,000
+15,250
| +10% | +$90.9K | 0.72% | 51 |
|
|
2018
Q1 | $898K | Buy |
153,750
+21,100
| +16% | +$123K | 0.81% | 45 |
|
|
2017
Q4 | $781K | Buy |
+132,650
| New | +$781K | 0.75% | 47 |
|